Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
3.36% (1D)
| Bid | 6.48 |
| Market Cap | 171.01M |
| Revenue (ttm) | 64.46M |
| Net Income (ttm) | -96.42M |
| EPS (ttm) | -4.32 |
| PE Ratio (ttm) | -1.85 |
| Forward PE | -2.14 |
| Analyst | Buy |
| Ask | 8.33 |
| Volume | 118,278 |
| Avg. Volume (20D) | 166,582 |
| Open | 7.80 |
| Previous Close | 7.74 |
| Day's Range | 7.57 - 8.03 |
| 52-Week Range | 4.09 - 13.43 |
| Beta | 0.88 |
About ENTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Enanta Pharmaceuticals has released their quartely earnings
on Aug 11, 2025:
Next Earnings Release
Enanta Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 24, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+8.51%
Enanta Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
2 months ago
+14.31%
Enanta Pharmaceuticals shares are trading higher after JMP Securities maintained an Outperform rating on the stock and raised its price target from $23 to $24.
1 month ago · businesswire.com
Enanta Pharmaceuticals to Participate in Baird's Biotech Discovery SeriesWATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological ...
2 months ago · businesswire.com
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceWATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological ...
